Genmab A/S (GMAB) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.093x

Based on the latest financial reports, Genmab A/S (GMAB) has a cash flow conversion efficiency ratio of 0.093x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Dkr536.00 Million ≈ $83.86 Million USD) by net assets (Dkr5.75 Billion ≈ $899.79 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See GMAB net asset quality score to measure how much of total assets are equity-financed.

Genmab A/S - Cash Flow Conversion Efficiency Trend (2002–2024)

This chart illustrates how Genmab A/S's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of Genmab A/S to evaluate the quality of earnings relative to operating cash generation.

Genmab A/S Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Genmab A/S ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Sieyuan Electric Co Ltd SHE:002028	0.071x
Norsk Hydro ASA OL:NHY	-0.017x
OMV AG ADR 1 F:OMVI	0.036x
Solar Industries India Limited NSE:SOLARINDS	0.015x
LG Electronics Inc KO:066570	0.061x
Dawning Information Industry Co Ltd SHG:603019	0.004x
SDIC Power Holdings Co Ltd SHG:600886	0.087x
Brookfield Infrastructure Partners L.P TO:BIP-UN	0.026x

Annual Cash Flow Conversion Efficiency for Genmab A/S (2002–2024)

The table below shows the annual cash flow conversion efficiency of Genmab A/S from 2002 to 2024. For the full company profile with market capitalisation and key ratios, see Genmab A/S market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Dkr36.70 Billion ≈ $5.74 Billion	Dkr7.77 Billion ≈ $1.22 Billion	0.212x	-9.30%
2023-12-31	Dkr31.61 Billion ≈ $4.95 Billion	Dkr7.38 Billion ≈ $1.15 Billion	0.233x	+62.82%
2022-12-31	Dkr27.28 Billion ≈ $4.27 Billion	Dkr3.91 Billion ≈ $612.06 Million	0.143x	+42.85%
2021-12-31	Dkr22.20 Billion ≈ $3.47 Billion	Dkr2.23 Billion ≈ $348.59 Million	0.100x	-70.16%
2020-12-31	Dkr19.12 Billion ≈ $2.99 Billion	Dkr6.43 Billion ≈ $1.01 Billion	0.336x	+256.43%
2019-12-31	Dkr14.05 Billion ≈ $2.20 Billion	Dkr1.33 Billion ≈ $207.46 Million	0.094x	-25.45%
2018-12-31	Dkr8.01 Billion ≈ $1.25 Billion	Dkr1.01 Billion ≈ $158.77 Million	0.127x	-50.02%
2017-12-31	Dkr6.27 Billion ≈ $981.33 Million	Dkr1.59 Billion ≈ $248.61 Million	0.253x	+273.12%
2016-12-31	Dkr4.83 Billion ≈ $755.17 Million	Dkr327.72 Million ≈ $51.27 Million	0.068x	-23.99%
2015-12-31	Dkr3.49 Billion ≈ $545.52 Million	Dkr311.45 Million ≈ $48.73 Million	0.089x	+36.87%
2014-12-31	Dkr2.03 Billion ≈ $318.07 Million	Dkr132.67 Million ≈ $20.76 Million	0.065x	+133.63%
2013-12-31	Dkr659.52 Million ≈ $103.19 Million	Dkr-128.00 Million ≈ $-20.03 Million	-0.194x	-204.86%
2012-12-31	Dkr383.19 Million ≈ $59.95 Million	Dkr70.92 Million ≈ $11.10 Million	0.185x	+120.59%
2011-12-31	Dkr486.42 Million ≈ $76.10 Million	Dkr-437.23 Million ≈ $-68.41 Million	-0.899x	-462.02%
2010-12-31	Dkr1.08 Billion ≈ $168.98 Million	Dkr268.17 Million ≈ $41.96 Million	0.248x	+156.50%
2009-12-31	Dkr1.30 Billion ≈ $202.96 Million	Dkr-570.06 Million ≈ $-89.19 Million	-0.439x	-87.36%
2008-12-31	Dkr2.19 Billion ≈ $342.42 Million	Dkr-513.33 Million ≈ $-80.31 Million	-0.235x	-233.68%
2007-12-31	Dkr2.88 Billion ≈ $451.11 Million	Dkr505.90 Million ≈ $79.15 Million	0.175x	+174.30%
2006-12-31	Dkr1.61 Billion ≈ $251.52 Million	Dkr-379.62 Million ≈ $-59.39 Million	-0.236x	-26.62%
2005-12-31	Dkr1.12 Billion ≈ $175.04 Million	Dkr-208.64 Million ≈ $-32.64 Million	-0.186x	+40.10%
2004-12-31	Dkr1.18 Billion ≈ $184.77 Million	Dkr-367.70 Million ≈ $-57.53 Million	-0.311x	-11.87%
2003-12-31	Dkr1.09 Billion ≈ $169.98 Million	Dkr-302.36 Million ≈ $-47.31 Million	-0.278x	-26.30%
2002-12-31	Dkr1.40 Billion ≈ $218.91 Million	Dkr-308.32 Million ≈ $-48.24 Million	-0.220x	--

About Genmab A/S

CO:GMAB Denmark Biotechnology

Market Cap

$17.91 Billion

Dkr114.48 Billion DKK

Market Cap Rank

#1406 Global

#8 in Denmark

Share Price

Dkr1858.50

Change (1 day)

+0.79%

52-Week Range

Dkr1357.50 - Dkr2251.00

All Time High

Dkr3295.00